青海地区短暂性脑缺血发作的危险因素
Risk Factors of Transient Ischemic Attack in Qinghai Area
DOI: 10.12677/ACM.2023.1351006, PDF,   
作者: 汤晨晨, 林 玲：青海大学研究生院，青海 西宁
关键词: TIA；青海地区；危险因素；TIA； Qinghai Area； Risk Factors
摘要: 短暂性脑缺血发作(TIA)是由于脑或脊髓血流损失导致的短暂性神经功能障碍，而没有急性梗死。TIA是严重的、需紧急干预的卒中预警事件，是最为重要的急症，同时也是二级预防的最佳时机，必须重视。目前其相关危险因素包括传统危险因素(年龄、吸烟、饮酒、高血压、糖尿病、高脂血症)及血清生物指标危险因素(高血液粘度、血红蛋白升高、高同型半胱氨酸血症、纤维蛋白原增高、胱抑素C升高、尿酸升高)。但高原地区TIA发病与其高原环境特点有关，高血液粘度在青海地区的发病中占主要地位。TIA是最终发生卒中的一个危险因素。教育患者和谆谆教导他们改变生活方式是减少短暂性脑缺血发作的最初步骤。
Abstract: Transient ischemic attack (TIA) is a transient neurological dysfunction caused by the loss of blood flow in the brain or spinal cord, without acute infarction. TIA is a serious stroke warning event that needs urgent intervention, the most important emergency and the best opportunity for secondary prevention, which must be paid attention to. At present, its related risk factors include traditional risk factors (age, smoking, drinking, hypertension, diabetes, hyperlipidemia) and serum biological index risk factors (high blood viscosity, elevated hemoglobin, hyperhomocysteinemia and increased fibrinogen). However, the onset of TIA in plateau area is related to the characteristics of plateau en-vironment, and high blood viscosity plays a major role in the onset of TIA in Qinghai area. TIA is a risk factor for eventual stroke. Educating patients and inculcating them to change their lifestyles are the first steps to reduce transient ischemic attacks.
文章引用：汤晨晨, 林玲. 青海地区短暂性脑缺血发作的危险因素[J]. 临床医学进展, 2023, 13(5): 7197-7202. https://doi.org/10.12677/ACM.2023.1351006

参考文献

[1] Go, A.S., Mozaffarian, D., Roger, V.L., et al. (2013) Heart Disease and Stroke Statistics—2013 Update. Circulation, 127, e6-e245. [Google Scholar] [CrossRef] 
[2] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6): 553-578.
[3] Feigin, V.L., Forouzanfar, M.H., Krishnamurthi, R., et al. (2010) Global and Regional Burden of Stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. Lancet, 383, 245-255. [Google Scholar] [CrossRef] 
[4] Jiang, B., Sun, H., Ru, X., et al. (2017) Prevalence, Inci-dence, Prognosis, Early Stroke Risk, and Stroke-Related Prognostic Factors of Definite or Probable Transient Ischemic Attacks in China, 2013. Frontiers in Neurology, 8, Article 309. [Google Scholar] [CrossRef] [PubMed]
[5] Easton, J. D., Saver, J. L., Albers, G. W., et al. (2009) Definition and Evaluation of Transient Ischemic Attack. Stroke, 40, 2276-2293. [Google Scholar] [CrossRef] 
[6] 短暂性脑缺血发作中国专家共识组. 短暂性脑缺血发作的中国专家共识更新版(2011年) [J]. 中华危重症医学杂志(电子版), 2012, 5(2): 100-105.
[7] Degan, D., Or-nello, R., Tiseo, C., et al. (2017) Epidemiology of Transient Ischemic Attacks Using Time- or Tissue-Based Definitions. Stroke, 48, 530-536. [Google Scholar] [CrossRef] 
[8] Khare, S. (2016) Risk Factors of Transient Ischemic Attack: An Overview. Journal of Mid-Life Health, 7, 2-7. [Google Scholar] [CrossRef] [PubMed]
[9] 吉维忠, 张亚清, 张豪, 等. 高海拔地区进展性脑卒中的相关因素分析[J]. 中国实用神经疾病杂志, 2016, 19(17): 36-38.
[10] 王陇德, 彭斌, 张鸿祺, 等. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志, 2022, 19(2): 136-144.
[11] 李春, 黄波, 韦朝阳. 短暂性脑缺血发作病因研究进展[J]. 解放军预防医学杂志, 2018, 36(2): 279-282.
[12] 刘杰, 王保爱. 短暂性脑缺血发作进展为脑梗死的相关危险因素研究进展[J]. 医学综述, 2021, 27(22): 4486-4490.
[13] 王辰, 肖丹, 池慧. 《中国吸烟危害健康报告2020》概要[J]. 中国循环杂志, 2021, 36(10): 937-952.
[14] Gan, Y., Wu, J., Li, L., et al. (2018) Association of Smoking with Risk of Stroke in Middle-Aged and Older Chinese: Evidence from the China National Stroke Prevention Project. Medicine, 97, e13260. [Google Scholar] [CrossRef] 
[15] Jones, S.B., Loehr, L., Avery, C.L., et al. (2015) Midlife Alcohol Consumption and the Risk of Stroke in the Atherosclerosis Risk in Communities Study. Stroke, 46, 3124-3130. [Google Scholar] [CrossRef] 
[16] 邹莉, 孟祥武. 缺血性脑卒中可预防性危险因素的研究进展[J]. 实用心脑肺血管病杂志, 2019, 27(11): 98-101, 106.
[17] 国家基本公共卫生服务项目基层高血压管理办公室, 基层高血压管理专家委员会. 国家基层高血压防治管理指南2020版[J]. 中国循环杂志, 2021, 36(3): 209-220.
[18] 林莹, 张宇清. 高原性高血压的患病率、发病机制及治疗研究进展[J]. 中华高血压杂志, 2020, 28(1): 82-86.
[19] 刘文宏, 张运, 毕欣伟, 等. 老年短暂性脑缺血发作患者早期预后不良的影响因素分析[J]. 中华行为医学与脑科学杂志, 2021, 30(1): 52-57.
[20] Grant, P.J. (2007) Diabetes Mellitus as a Prothrombotic Condi-tion. Journal of Internal Medicine, 262, 157-172. [Google Scholar] [CrossRef] [PubMed]
[21] Jové, M., Mauri-Capdevila, G., Suárez, I., et al. (2014) Metabolomics Predicts Stroke Recurrence after Transient Ischemic Attack. Neurology, 84, 36-45. [Google Scholar] [CrossRef] 
[22] Fonville, S., Zandbergen, A.A., Koudstaal, P.J. and Den Hertog, H.M. (2014) Prediabetes in Patients with Stroke or Transient Ischemic Attack: Prevalence, Risk and Clinical Management. Cerebrovascular Diseases, 37, 393-400. [Google Scholar] [CrossRef] [PubMed]
[23] 李军. 高原短暂性脑缺血发作临床与相关危险因子分析[J]. 高原医学杂志, 2004, 14(4): 16-18.
[24] Ma, Y., Zhao, X., Zhang, W., et al. (2009) Homocysteine and Ischemic Stroke Subtype: A Relationship Study in Chinese Patients. Neurological Research, 32, 636-641. [Google Scholar] [CrossRef] 
[25] Kamat, P.K., Vacek, J.C., Kalani, A. and Tyagi, N. (2015) Homocysteine Induced Cerebrovascular Dysfunction: A Link to Alzheimer’s Disease Etiology. The Open Neu-rology Journal, 9, 9-14. [Google Scholar] [CrossRef] 
[26] Huang, S., Yin, L., Xu, Y., Zou, C. and Chen, L. (2016) The Homocysteine Associated Variant rs548987 of SLC17A3 Confers Susceptibility to Ischemic Stroke in Chinese Popula-tion. Journal of the Neurological Sciences, 370, 78-81. [Google Scholar] [CrossRef] [PubMed]
[27] Zulli, A. (2016) Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease. Current Pharmaceutical Design, 22, 2704-2708. [Google Scholar] [CrossRef] [PubMed]
[28] Katsiki, N., Perez-Martinez, P. and Mikhailidis, D.P. (2017) Homocysteine and Non-Cardiac Vascular Disease. Current Pharmaceutical Design, 23, 3224-3232. [Google Scholar] [CrossRef] [PubMed]
[29] Pedersen, A., Stanne, T.M., Redfors, P., et al. (2018) Fibrinogen Concentrations Predict Long-Term Cognitive Outcome in Young Ischemic Stroke Patients. Research and Practice in Thrombosis and Haemostasis, 2, 339-346. [Google Scholar] [CrossRef] [PubMed]
[30] Luo, H., Li, X., Jiang, A., et al. (2018) Associations of β-Fibrinogen Pol-ymorphisms with the Risk of Ischemic Stroke: A Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 28, 243-250. [Google Scholar] [CrossRef] [PubMed]
[31] 刘斌, 李梦雨, 董亚楠, 等. ABCD3-I评分联合炎性和凝血指标检测对短暂性脑缺血发作近期发生脑梗死的预测[J]. 中华老年心脑血管病杂志, 2020, 22(1): 52-55.
[32] Velibor, Č. (2015) Cystatin C—More Than the Marker of the Glomerular Filtration Rate. Medicinski Pregled, 68, 173-179. [Google Scholar] [CrossRef] 
[33] Luo, J., Wang, L.-P., Hu, H.-F., et al. (2015) Cystatin C and Cardiovascular or All-Cause Mortality Risk in the General Population: A Meta-Analysis. Clinica Chimica Acta, 450, 39-45. [Google Scholar] [CrossRef] [PubMed]
[34] Jung, E., Ro, Y.S., Ryu, H.H., et al. (2022) Cys-tatin C and Mortality Risk in the General Population: Systematic Review and Dose Response Meta-Analysis. Biomarkers, 27, 222-229. [Google Scholar] [CrossRef] 
[35] Xu, Z., Leng, C., Yang, B., et al. (2017) Se-rum Cystatin C Is Associated with Large Cerebral Artery Stenosis in Acute Ischemic Stroke. Oncotarget, 8, 67181-67188. [Google Scholar] [CrossRef] [PubMed]
[36] Ndrepepa, G. (2018) Uric acid and Cardiovascular Disease. Clinica Chimica Acta, 484, 150-163. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, S., Liu, L., Huang, Y.-Q., et al. (2020) The Association be-tween Serum Uric Acid Levels and Ischemic Stroke in Essential Hypertension Patients. Postgraduate Medicine, 132, 551-558. [Google Scholar] [CrossRef] [PubMed]
[38] 刘新生, 张瑞锋, 冯丽君, 等. 短暂性脑缺血发作病人血清尿酸及胱抑素C水平与颈内动脉狭窄的关系[J]. 中西医结合心脑血管病杂志, 2020, 18(2): 331-333.
[39] Tariq, M.A., Shamim, S.A., Rana, K.F., Saeed, A. and Malik, B.H. (2019) Serum Uric Acid-Risk Factor for Acute Ischemic Stroke and Poor Outcomes. Cureus, 11, e6007. [Google Scholar] [CrossRef] [PubMed]

为你推荐